Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 25 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Lung cancerThis series is part of our curated briefing on it.
- Samples
- 25 samples: 11 × CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, vs 11 × CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Cytotoxic CD39(+) tumor-associated NK cells respond to NKG2A blockade in lung cancerScience immunology · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE334763_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1476292. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 2 samples read as cases, 22 as controls.
How we read this: 2 replicated groups read from 25 sample titles; they account for 22 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9156070 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 1 CD56⁺ NK and T cells so…
- GSM9156071 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 1 CD56⁺ NK and T cells so…
- GSM9156072 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 2 CD56⁺ NK and T cells so…
- GSM9156073 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 2 CD56⁺ NK and T cells so…
- GSM9156074 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 3 CD56⁺ NK and T cells so…
- GSM9156075 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 3 CD56⁺ NK and T cells so…
- GSM9156076 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 4 CD56⁺ NK and T cells so…
- GSM9156077 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 4 CD56⁺ NK and T cells so…
- GSM9156078 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 5 CD56⁺ NK and T cells so…
- GSM9156079 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 5 CD56⁺ NK and T cells so…
- GSM9156080 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 6 CD56⁺ NK and T cells so…
- GSM9156081 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 6 CD56⁺ NK and T cells so…
- GSM9156082 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 7 CD56⁺ NK and T cells so…
- GSM9156083 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 7 CD56⁺ NK and T cells so…
- GSM9156084 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 8 CD56⁺ NK and T cells so…
- GSM9156085 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 8 CD56⁺ NK and T cells so…
- GSM9156086 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 9 CD56⁺ NK and T cells so…
- GSM9156087 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 9 CD56⁺ NK and T cells so…
- GSM9156088 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 10 CD56⁺ NK and T cells so…
- GSM9156089 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 10 CD56⁺ NK and T cells so…
- GSM9156090 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 11 CD56⁺ NK and T cells so…
- GSM9156091 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 11 CD56⁺ NK and T cells so…
- GSM9525785 LuT722_Lung_Adenocarcinoma_Tumor_core
- GSM9525786 LuT722_Lung_Adenocarcinoma_adjacent_lung
- GSM9525787 LuT722_Lung_Adenocarcinoma_invasive_front
- GSE114761 Transforming Growth Factor β-Induced Epithelial-to-Mesenchymal Signature Predicts Metastasis-Free Survival in Non-Small Cell Lung Cancer. 42 samples same disease briefing · shares lung
- GSE127465 Single cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species 40 samples same disease briefing · shares lung
- GSE103550 Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 24 samples same disease briefing · shares lung
- GSE241518 High-throughout sequencing of colorectal cancer and non-small cell lung cancer cells treated actived compound YHM18 4 samples same disease briefing · shares lung
- GSE10072 Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival 107 samples same disease briefing · shares lung
- GSE17958 Affymetrix SNP array data for 47 lung squamous cell carcinoma and 40 esophageal squamous cell carcinoma samples. 87 samples same disease briefing · shares lung
- GSE104244 Bone Marrow Derived Macrophages, NSCLC cell lines, and Kras G12D Lung Tumors Treated with Epigenetic Agents 33 samples same disease briefing · shares lung
- GSE27389 Substitutions in the KRas oncogene determine protein behavior: Implications for signaling and clinical outcome. 22 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.